Preoperative glucose as a screening tool in patients without diabetes

Rui Wang, Maria T. Panizales, Margo S. Hudson, Selwyn O. Rogers, Jeffrey L. Schnipper

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background Although hyperglycemia has been associated with poor postoperative outcomes, preoperative hyperglycemia is not used as a screening tool in patients without diabetes. We evaluated preoperative glucose as a marker for postoperative outcomes in patients without diabetes to assess its usefulness as a potential screening tool. Materials and methods Clinical characteristics for a sample of 6683 patients without diabetes who underwent nonemergent vascular and general surgery were collected from the American College of Surgeons National Surgical Quality Improvement Program, Brigham and Women's Hospital database. Last glucose measured within 30 d before surgery was the main predictor variable with postoperative infection within 30 d as the primary outcome. Results For patients without known diabetes with preoperative glucose of 100-139 and 140-179 mg/dL, postoperative infection rates were significantly higher (9.33% and 10.16%, respectively) than that of patients with preoperative glucose of 70-99 mg/dL (5.62%, P < 0.001). The risk-adjusted odds of postoperative infection increased by 40% (95% CI, 13%-72%) for each 40 mg/dL increase in preoperative glucose over the range 70-179 mg/dL. Follow-up data demonstrated that 15% of patients with preoperative glucose ≥100 mg/dL were diagnosed with diabetes within 1 y after surgery. Conclusions In patients without known diabetes, preoperative glucose is a significant marker for postoperative complications even at moderate levels of hyperglycemia. Some of these patients likely had prediabetes or unrecognized diabetes at the time of surgery. Further studies are needed to determine whether such screening and follow-up of preoperative hyperglycemia in all patients would be effective in lowering complication rates.

Original languageEnglish (US)
Pages (from-to)371-378
Number of pages8
JournalJournal of Surgical Research
Volume186
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Fingerprint

Glucose
Hyperglycemia
Infection
Prediabetic State
Quality Improvement
Blood Vessels
Databases

Keywords

  • Postoperative complications
  • Preoperative screening
  • Undiagnosed hyperglycemia

ASJC Scopus subject areas

  • Surgery

Cite this

Wang, R., Panizales, M. T., Hudson, M. S., Rogers, S. O., & Schnipper, J. L. (2014). Preoperative glucose as a screening tool in patients without diabetes. Journal of Surgical Research, 186(1), 371-378. https://doi.org/10.1016/j.jss.2013.09.014

Preoperative glucose as a screening tool in patients without diabetes. / Wang, Rui; Panizales, Maria T.; Hudson, Margo S.; Rogers, Selwyn O.; Schnipper, Jeffrey L.

In: Journal of Surgical Research, Vol. 186, No. 1, 01.2014, p. 371-378.

Research output: Contribution to journalArticle

Wang, R, Panizales, MT, Hudson, MS, Rogers, SO & Schnipper, JL 2014, 'Preoperative glucose as a screening tool in patients without diabetes', Journal of Surgical Research, vol. 186, no. 1, pp. 371-378. https://doi.org/10.1016/j.jss.2013.09.014
Wang, Rui ; Panizales, Maria T. ; Hudson, Margo S. ; Rogers, Selwyn O. ; Schnipper, Jeffrey L. / Preoperative glucose as a screening tool in patients without diabetes. In: Journal of Surgical Research. 2014 ; Vol. 186, No. 1. pp. 371-378.
@article{0536b900ddf049ec97fbe2757a2896ab,
title = "Preoperative glucose as a screening tool in patients without diabetes",
abstract = "Background Although hyperglycemia has been associated with poor postoperative outcomes, preoperative hyperglycemia is not used as a screening tool in patients without diabetes. We evaluated preoperative glucose as a marker for postoperative outcomes in patients without diabetes to assess its usefulness as a potential screening tool. Materials and methods Clinical characteristics for a sample of 6683 patients without diabetes who underwent nonemergent vascular and general surgery were collected from the American College of Surgeons National Surgical Quality Improvement Program, Brigham and Women's Hospital database. Last glucose measured within 30 d before surgery was the main predictor variable with postoperative infection within 30 d as the primary outcome. Results For patients without known diabetes with preoperative glucose of 100-139 and 140-179 mg/dL, postoperative infection rates were significantly higher (9.33{\%} and 10.16{\%}, respectively) than that of patients with preoperative glucose of 70-99 mg/dL (5.62{\%}, P < 0.001). The risk-adjusted odds of postoperative infection increased by 40{\%} (95{\%} CI, 13{\%}-72{\%}) for each 40 mg/dL increase in preoperative glucose over the range 70-179 mg/dL. Follow-up data demonstrated that 15{\%} of patients with preoperative glucose ≥100 mg/dL were diagnosed with diabetes within 1 y after surgery. Conclusions In patients without known diabetes, preoperative glucose is a significant marker for postoperative complications even at moderate levels of hyperglycemia. Some of these patients likely had prediabetes or unrecognized diabetes at the time of surgery. Further studies are needed to determine whether such screening and follow-up of preoperative hyperglycemia in all patients would be effective in lowering complication rates.",
keywords = "Postoperative complications, Preoperative screening, Undiagnosed hyperglycemia",
author = "Rui Wang and Panizales, {Maria T.} and Hudson, {Margo S.} and Rogers, {Selwyn O.} and Schnipper, {Jeffrey L.}",
year = "2014",
month = "1",
doi = "10.1016/j.jss.2013.09.014",
language = "English (US)",
volume = "186",
pages = "371--378",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Preoperative glucose as a screening tool in patients without diabetes

AU - Wang, Rui

AU - Panizales, Maria T.

AU - Hudson, Margo S.

AU - Rogers, Selwyn O.

AU - Schnipper, Jeffrey L.

PY - 2014/1

Y1 - 2014/1

N2 - Background Although hyperglycemia has been associated with poor postoperative outcomes, preoperative hyperglycemia is not used as a screening tool in patients without diabetes. We evaluated preoperative glucose as a marker for postoperative outcomes in patients without diabetes to assess its usefulness as a potential screening tool. Materials and methods Clinical characteristics for a sample of 6683 patients without diabetes who underwent nonemergent vascular and general surgery were collected from the American College of Surgeons National Surgical Quality Improvement Program, Brigham and Women's Hospital database. Last glucose measured within 30 d before surgery was the main predictor variable with postoperative infection within 30 d as the primary outcome. Results For patients without known diabetes with preoperative glucose of 100-139 and 140-179 mg/dL, postoperative infection rates were significantly higher (9.33% and 10.16%, respectively) than that of patients with preoperative glucose of 70-99 mg/dL (5.62%, P < 0.001). The risk-adjusted odds of postoperative infection increased by 40% (95% CI, 13%-72%) for each 40 mg/dL increase in preoperative glucose over the range 70-179 mg/dL. Follow-up data demonstrated that 15% of patients with preoperative glucose ≥100 mg/dL were diagnosed with diabetes within 1 y after surgery. Conclusions In patients without known diabetes, preoperative glucose is a significant marker for postoperative complications even at moderate levels of hyperglycemia. Some of these patients likely had prediabetes or unrecognized diabetes at the time of surgery. Further studies are needed to determine whether such screening and follow-up of preoperative hyperglycemia in all patients would be effective in lowering complication rates.

AB - Background Although hyperglycemia has been associated with poor postoperative outcomes, preoperative hyperglycemia is not used as a screening tool in patients without diabetes. We evaluated preoperative glucose as a marker for postoperative outcomes in patients without diabetes to assess its usefulness as a potential screening tool. Materials and methods Clinical characteristics for a sample of 6683 patients without diabetes who underwent nonemergent vascular and general surgery were collected from the American College of Surgeons National Surgical Quality Improvement Program, Brigham and Women's Hospital database. Last glucose measured within 30 d before surgery was the main predictor variable with postoperative infection within 30 d as the primary outcome. Results For patients without known diabetes with preoperative glucose of 100-139 and 140-179 mg/dL, postoperative infection rates were significantly higher (9.33% and 10.16%, respectively) than that of patients with preoperative glucose of 70-99 mg/dL (5.62%, P < 0.001). The risk-adjusted odds of postoperative infection increased by 40% (95% CI, 13%-72%) for each 40 mg/dL increase in preoperative glucose over the range 70-179 mg/dL. Follow-up data demonstrated that 15% of patients with preoperative glucose ≥100 mg/dL were diagnosed with diabetes within 1 y after surgery. Conclusions In patients without known diabetes, preoperative glucose is a significant marker for postoperative complications even at moderate levels of hyperglycemia. Some of these patients likely had prediabetes or unrecognized diabetes at the time of surgery. Further studies are needed to determine whether such screening and follow-up of preoperative hyperglycemia in all patients would be effective in lowering complication rates.

KW - Postoperative complications

KW - Preoperative screening

KW - Undiagnosed hyperglycemia

UR - http://www.scopus.com/inward/record.url?scp=84890129597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890129597&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2013.09.014

DO - 10.1016/j.jss.2013.09.014

M3 - Article

C2 - 24148355

AN - SCOPUS:84890129597

VL - 186

SP - 371

EP - 378

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -